World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 17 October 2012
Main ID:  NCT00577876
Date of registration: 18/12/2007
Primary sponsor: Memorial Sloan-Kettering Cancer Center
Public title: Assessment of the Functional Significance of Accessory Pudendal Arteries
Scientific title: Assessment of the Functional Significance of Accessory Pudendal Arteries
Date of first enrolment: September 2006
Target sample size: 38
Recruitment status: Completed
URL:  http://clinicaltrials.gov/show/NCT00577876
Study type:  Interventional
Study design:  Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment  
Countries of recruitment
United States
Contacts
Name:   John Mulhall, MD
Address: 
Telephone:
Email:
Affiliation:  Memorial Sloan-Kettering Cancer Center
Key inclusion & exclusion criteria

Inclusion Criteria:

- They have selected a LRP, with or without robotic assistance, by Jonathan Colelman,
MD, Bertrand Guillonneau, MD, Vincent Laudone, MD, Raul Parra, MD, or Karim Touijer
MD for definitive treatment of their prostate cancer after a full discussion of
treatment options.

Exclusion Criteria:

- Patients undergoing Open Radical Prostatectomy

- Patients with prior history of insulin dependent diabetes mellitus

- Patient who have received prior radiation therapy to the pelvis or prostate

- Patients requiring anticoagulation postoperatively

- Known allergy to Phenylephrine, Alprostadil, Papaverine or Phentolamine

- Patients whose systolic blood pressure is below 90 mmHg at the time of evaluation
despite routine measures taken by the anesthesiologist at his best criteria.

- Patients with labile hypertension or history of prior priapism

- Patients with penile scarring or penile prosthesis

- Patients with an International Index of Erectile Function score < 24



Age minimum: 18 Years
Age maximum: N/A
Gender: Male
Health Condition(s) or Problem(s) studied
Prostate Cancer
Intervention(s)
Procedure: Trimix Injection with Doppler Ultrasound
Primary Outcome(s)
To determine the proportion of men with APAs for whom APAs contribute to penile blood flow [Time Frame: 18 mo]
Secondary Outcome(s)
To describe peak systolic, diastolic and resistive index velocities of the dorsal artery of the penis before and after clamping of the APA. [Time Frame: 18 mo]
Secondary ID(s)
06-073
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history